Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,623	16,614	15,082	17,193	35,911	69,826
Market Cap Growth	-8.10%	10.16%	-12.28%	-52.12%	-48.57%	4.58%
Enterprise Value	11,858	14,070	13,285	17,038	34,790	61,349
Last Close Price	291.00	331.00	303.00	394.00	824.00	1601.01
PE Ratio	17.13	18.50	-	-	-	16.71
Forward PE	55.43	-	-	-	-	13.48
PS Ratio	2.46	2.64	2.46	3.41	3.18	3.11
PB Ratio	1.78	2.09	2.24	2.14	2.80	3.07
P/TBV Ratio	1.78	2.09	2.24	2.20	2.87	3.11
P/FCF Ratio	-	81.04	-	-	-	-
P/OCF Ratio	-	45.90	-	-	-	-
PEG Ratio	-	4.03	4.03	4.03	4.03	4.03
EV/Sales Ratio	2.00	2.24	2.17	3.38	3.08	2.73
EV/EBITDA Ratio	24.40	15.88	-	-	-	8.89
EV/EBIT Ratio	52.01	22.33	-	-	-	9.78
EV/FCF Ratio	-	68.64	-	-	-	-
Debt / Equity Ratio	0.12	0.26	0.48	0.47	0.37	0.00
Debt / EBITDA Ratio	2.10	2.29	-	-	-	0.01
Debt / FCF Ratio	-	9.89	-	-	-	-
Asset Turnover	0.48	0.48	0.43	0.27	0.42	-
Inventory Turnover	1.43	1.72	2.13	1.54	1.78	-
Quick Ratio	2.50	2.44	2.45	1.90	2.35	1.72
Current Ratio	3.53	3.07	2.99	2.71	3.19	2.65
Return on Equity (ROE)	10.47%	12.22%	-48.86%	-46.96%	-53.92%	-
Return on Assets (ROA)	1.16%	3.01%	-4.45%	-10.24%	-11.39%	-
Return on Invested Capital (ROIC)	1.48%	3.94%	-5.76%	-13.07%	-15.29%	-
Return on Capital Employed (ROCE)	2.40%	6.30%	-9.90%	-25.10%	-27.20%	25.80%
Earnings Yield	5.83%	5.41%	-23.94%	-28.47%	-26.72%	5.98%
FCF Yield	-	1.23%	-2.68%	-11.97%	-8.55%	-6.99%
Dividend Yield	-	-	-	-	-	1.48%
Payout Ratio	-	0.11%	-	-	-	26.97%
Buyback Yield / Dilution	-0.25%	-5.96%	-8.62%	-0.21%	-0.35%	-1.32%
Total Shareholder Return	-0.25%	-5.96%	-8.62%	-0.21%	-0.35%	0.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.